Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.

Krabbe CA, Balink H, Roodenburg JL, Dol J, de Visscher JG.

Int J Oral Maxillofac Surg. 2011 Nov;40(11):1263-70. doi: 10.1016/j.ijom.2011.06.023. Epub 2011 Aug 6.

PMID:
21824748
2.

FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.

Suenaga Y, Kitajima K, Ishihara T, Sasaki R, Otsuki N, Nibu K, Minamikawa T, Kiyota N, Sugimura K.

Eur Radiol. 2016 Apr;26(4):1018-30. doi: 10.1007/s00330-015-3902-1. Epub 2015 Jul 19.

PMID:
26188656
4.
5.

18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?

Kendi AT, Corey A, Magliocca KR, Nickleach DC, Galt J, Switchenko JM, El-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM.

Eur J Radiol. 2015 Jun;84(6):1171-6. doi: 10.1016/j.ejrad.2015.02.030. Epub 2015 Mar 14.

6.

The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction.

Müller J, Hüllner M, Strobel K, Huber GF, Burger IA, Haerle SK.

Laryngoscope. 2015 Aug;125(8):1861-8. doi: 10.1002/lary.25326. Epub 2015 Apr 17.

PMID:
25892275
7.

Preoperative 18F-FDG-PET/CT vs Contrast-Enhanced CT to Identify Regional Nodal Metastasis among Patients with Head and Neck Squamous Cell Carcinoma.

Cho JK, Ow TJ, Lee AY, Smith RV, Schlecht NF, Schiff BA, Tassler AB, Lin J, Moadel RM, Valdivia A, Abraham T, Gulko E, Neimark M, Ustun B, Bello JA, Shifteh K.

Otolaryngol Head Neck Surg. 2017 Sep;157(3):439-447. doi: 10.1177/0194599817703927. Epub 2017 Jun 13.

PMID:
28608737
8.

Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.

Piao Y, Bold B, Tayier A, Ishida R, Omura K, Okada N, Shibuya H.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Dec;108(6):933-8. doi: 10.1016/j.tripleo.2009.07.054. Epub 2009 Oct 28. No abstract available.

PMID:
19846326
9.

Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.

Nayak B, Dogra PN, Naswa N, Kumar R.

Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):386-93. doi: 10.1007/s00259-012-2294-6. Epub 2012 Nov 24.

PMID:
23179944
10.

18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.

Krabbe CA, Pruim J, Scholtens AM, Roodenburg JL, Brouwers AH, Phan TT, Agool A, Dijkstra PU.

J Oral Maxillofac Surg. 2010 Jan;68(1):21-7. doi: 10.1016/j.joms.2009.07.021.

PMID:
20006150
11.
12.

Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with (18)F-FDG PET.

Krabbe CA, van der Werff-Regelink G, Pruim J, van der Wal JE, Roodenburg JL.

Head Neck. 2010 Mar;32(3):368-74. doi: 10.1002/hed.21192.

PMID:
19626632
13.

FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.

Krabbe CA, Dijkstra PU, Pruim J, van der Laan BF, van der Wal JE, Gravendeel JP, Roodenburg JL.

Oral Oncol. 2008 Jan;44(1):31-6. Epub 2007 Feb 15.

PMID:
17306603
14.

18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.

Roh JL, Park JP, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.

Radiology. 2014 Apr;271(1):153-61. doi: 10.1148/radiol.13131470. Epub 2013 Nov 23.

PMID:
24475791
15.

Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.

Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S.

BJU Int. 2013 Oct;112(6):729-34. doi: 10.1111/bju.12109. Epub 2013 Jun 24.

16.

Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.

Stuckensen T, Kovács AF, Adams S, Baum RP.

J Craniomaxillofac Surg. 2000 Dec;28(6):319-24.

PMID:
11465137
17.

Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.

Hong HR, Jin S, Koo HJ, Roh JL, Kim JS, Cho KJ, Choi SH, Nam SY, Kim SY.

J Surg Oncol. 2014 Nov;110(6):696-701. doi: 10.1002/jso.23691. Epub 2014 Jul 3.

PMID:
24995957
18.

Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?

van Hamersvelt HP, Kwee TC, Fijnheer R, Beek FJ, de Klerk JM, Nievelstein RA.

J Comput Assist Tomogr. 2014 Jul-Aug;38(4):620-5. doi: 10.1097/RCT.0000000000000067.

PMID:
24681861
19.

18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.

Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.

J Nucl Med. 2005 Jul;46(7):1136-43.

20.

Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.

Goerres GW, Schmid DT, Grätz KW, von Schulthess GK, Eyrich GK.

Oral Oncol. 2003 Sep;39(6):547-51.

PMID:
12798396

Supplemental Content

Support Center